Myocardial Steatosis Among Antiretroviral Therapy–Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial

BACKGROUND: People with human immunodeficiency virus (PWH) face increased risks for heart failure and adverse heart failure outcomes. Myocardial steatosis predisposes to diastolic dysfunction, a heart failure precursor. We aimed to characterize myocardial steatosis and associated potential risk fact...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Infect Dis
Hlavní autoři: Neilan, Tomas G, Nguyen, Kim-Lien, Zaha, Vlad G, Chew, Kara W, Morrison, Leavitt, Ntusi, Ntobeko A B, Toribio, Mabel, Awadalla, Magid, Drobni, Zsofia D, Nelson, Michael D, Burdo, Tricia H, Van Schalkwyk, Marije, Sax, Paul E, Skiest, Daniel J, Tashima, Karen, Landovitz, Raphael J, Daar, Eric, Wurcel, Alysse G, Robbins, Gregory K, Bolan, Robert K, Fitch, Kathleen V, Currier, Judith S, Bloomfield, Gerald S, Desvigne-Nickens, Patrice, Douglas, Pamela S, Hoffmann, Udo, Grinspoon, Steven K, Ribaudo, Heather, Dawson, Rodney, Goetz, Matthew Bidwell, Jain, Mamta K, Warner, Alberta, Szczepaniak, Lidia S, Zanni, Markella V
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Supplement Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7347082/
https://ncbi.nlm.nih.gov/pubmed/32645158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa245
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky